AbbVie has rewarded shareholders again with a quarterly dividend. As a Dividend King, it is the epitome of a steady and ...

With 2025 on the horizon, investors are sharpening their focus on the year ahead, selecting portfolio additions that aim to ...

expanding the tokenized asset industry will need more traditional investors which, in turn, are demanding more ...

Shares of major U.S. drugmakers fell on Friday after President-elect Donald Trump picked anti-vaccine activist Robert F.

(NASDAQ:BLUE) traded lower for the fourth straight session as Bank of America and J.P. Morgan downgraded the gene therapy developer after its Q3 2024 results fell short of expectations for ...

Palm biometrics are hot and major players are investing heavily. Palm is emerging as a modality of choice for retail payments ...

The Wall Street giant announced Friday that Burke Davis, who has been at J.P. Morgan since 2012, will take over Herrick’s role as head of real estate banking (REB) and report to her in the key lending ...

J.P. Morgan is targeting tech startups as clients after Silicon Valley Bank, First Republic Bank and Silvergate Bank ...

Curious about how to sell luxury real estate? Learn strategies to attract high-end buyers and boost your property’s value in ...

As more wealthy empty nesters stick to the North Shore rather than move to the Loop, the banking giant says they're looking ...

J.P. Morgan analyst Lisa Gill maintained a Hold rating on Humana (HUM – Research Report) yesterday and set a price target of $257.00. The ...

J.P. Morgan analyst Ryan Brinkman maintained a Buy rating on Aptiv (APTV – Research Report) on November 11 and set a price target of ...